RhumbLine Advisers
RAPP

RhumbLine Advisers’s Rapport Therapeutics RAPP Stock Holding History

RhumbLine Advisers’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$284K Buy
24,949
+10,591
+74% +$120K ﹤0.01% 3020
2025
Q1 		$144K Buy
14,358
+4,109
+40% +$41.2K ﹤0.01% 3273
2024
Q4 		$182K Sell
10,249
-5,594
-35% -$99.2K ﹤0.01% 3242
2024
Q3 		$324K Buy
+15,843
New +$324K ﹤0.01% 2978